Prevalence and Cost of Medication Nonadherence in Parkinson's Disease: Evidence from Administrative Claims Data

被引:75
作者
Davis, Keith L. [1 ]
Edin, Heather M. [2 ]
Allen, Jeffery K. [2 ]
机构
[1] RTI Hlth Solut, Hlth Econ, Res Triangle Pk, NC 27709 USA
[2] GlaxoSmithKline, Res Triangle Pk, NC USA
关键词
Parkinson's disease; nonadherence; costs; claims data; ADHERENCE; NONCOMPLIANCE; MULTICENTER; BURDEN;
D O I
10.1002/mds.22999
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We estimated the prevalence of medication nonadherence in Parkinson's disease (PD) and the association between treatment nonadherence and healthcare costs. Insurance claims from over 30 US health plans were analyzed. Inclusion criteria were as follows: PD diagnosis, PD-related prescription between 1/1/1997 and 12/31/2004, continuous health plan enrollment for months before and >= 12 months after first PD prescription. Adherence, all-cause healthcare utilization, and all-cause costs were evaluated over 12 months post-treatment initiation. Adherence was measured using the medication possession ratio (MPR), with MPR < 0.8 defining nonadherence. Among patients identified for inclusion (N = 3,119), 58% were male and mean age was 69 years. Mean MPR was 0.58 and 61% of patients were nonadherent. Unadjusted mean medical costs were significantly higher (P < 0.01) among nonadherers ($15,826) compared with adherers ($9,228), although nonadherers had lower prescription drug costs ($2,684 vs. $3,854; P < 0.05). After controlling for confounders in multivariable analyses, a large positive relationship between nonadherence and both medical and total healthcare costs remained (+$3,451, P < 0.0001 and +$2,383, P = 0.0053, respectively). Medication adherence in PD is suboptimal and nonadherence may be associated with increased healthcare costs despite offsets from reduced drug intake. Efforts to promote medication adherence in PD may lead to cost savings for managed care systems. (C) 2010 Movement Disorder Society
引用
收藏
页码:474 / 480
页数:7
相关论文
共 31 条
[1]   Methods for evaluation of medication adherence and persistence using automated databases [J].
Andrade, Susan E. ;
Kahler, Kristijan H. ;
Frech, Feride ;
Chan, K. Arnold .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 (08) :565-574
[2]   Noncompliance with medication for psychiatric disorders - Reasons and remedies [J].
Breen, R ;
Thornhill, JT .
CNS DRUGS, 1998, 9 (06) :457-471
[3]   Factors influencing compliance with antiepileptic drug regimes [J].
Buck, D ;
Jacoby, A ;
Baker, GA ;
Chadwick, DW .
SEIZURE, 1997, 6 (02) :87-93
[4]   PATIENTS COOPERATION WITH A MEDICAL REGIMEN - DIFFICULTIES IN IDENTIFYING NONCOOPERATOR [J].
CARON, HS ;
ROTH, HP .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1968, 203 (11) :922-&
[5]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[6]  
Chaudhuri KR, 2004, J NEUROL NEUROSUR PS, V75, P516
[7]   A systematic review of the associations between dose regimens and medication compliance [J].
Claxton, AJ ;
Cramer, J ;
Pierce, C .
CLINICAL THERAPEUTICS, 2001, 23 (08) :1296-1310
[8]   Treatment adherence in chronic disease [J].
Dunbar-Jacob, J ;
Mortimer-Stephens, MK .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2001, 54 :S57-S60
[9]   Self-reported adherence versus pill count in Parkinson's disease: The NET-PD experience [J].
Elm, Jordan J. ;
Kamp, Cornelia ;
Tilley, Barbara C. ;
Guimaraes, Paulo ;
Fraser, Debbie ;
Deppen, Patricia ;
Brocht, Alicia ;
Weaver, Chris ;
Bennett, Susan .
MOVEMENT DISORDERS, 2007, 22 (06) :822-827
[10]   UNDERSTANDING AND IMPROVING PATIENT COMPLIANCE [J].
ERAKER, SA ;
KIRSCHT, JP ;
BECKER, MH .
ANNALS OF INTERNAL MEDICINE, 1984, 100 (02) :258-268